Contrary to its established role as a prognostic marker in luminal breast cancer, we discovered that SIGLEC15 exhibits dual functionality in TNBC, simultaneously regulating tumor biological behavior and immune modulation within the TME. The gene discussed is SIGLEC15; the disease is breast cancer.